Beclometasone/formoterol/glycopyrronium pMDI for severe asthma

Description

In this Product Explainer, Respiratory Physician Dr Andrew Scroop explains the role of beclometasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment in adult patients with uncontrolled asthma despite treatment with an ICS and a LABA with a history of exacerbations (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Karam Kostner

A/Prof Karam Kostner

LDL Management – Why it is Important

A/Prof Ralph Audehm

A/Prof Ralph Audehm

Navigating Expanded PBS Access to SGLT2i in General Practice

Prof Deborah Bateson

Prof Deborah Bateson

Cervical Cancer Prevention – Common Questions

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Asthma Cases – When to Use Dual vs Triple Therapy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Andrew Scroop

expert

Dr Andrew Scroop

Respiratory Physician; Founding Director of Respiratory Consultants, St Andrews Medical Centre

Date published: 24 January 2025